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Alpha-fetoprotein (AFP), ~  a normal component of fetal and newborn sera, has 
been shown in beth the human and murine systems to exert selective suppres- 
sive effects on various functions of thymus-derived (T) lymphocytes, including 
T-cell-dependent antibody synthesis, T-cell mitogenic responsiveness,  and T- 
cell-mediated allogeneic reactivity (1-9). 2 In addition, recent reports have also 
revealed that under special circumstances AFP may exert a  supportive influ- 
ence on in vitro cell growth (9-11) with one important manifestation of this 
activating property being the in vitro induction of suppressor T cells (12). 
We have undertaken a study into the possible regulatory influence of AFP on 
the  recognitive  and  effector  phases  of  T-cell-mediated  allogeneic  immune 
reactions utilizing the in vitro mixed leukocyte culture (MLC) and cell-mediated 
lympholysis (CML)  assays.  In a  preceding paper  (9),  we presented evidence 
that fetal-derived AFP can exert major differential effects on both the primary 
and secondary MLC responses of purified T lymphocyte subpopulations ranging 
from strong suppression to occasional enhancement. Genetic analysis revealed 
that T-cell proliferation dependent on the recognition of major histocompatibil- 
ity  complex  (MHC)  I  region  gene  determinants  was  actively  suppressed, 
whereas  proliferative  responses  induced by  MHC  serologically-defined (SD) 
region  histoincompatibilities  and  I  region-independent non-MHC  differences 
were generally unaffected. 
In view of these findings, one might predict that AFP would fail to suppress 
the  development of cytotexic T  lymphocytes (CTLs)  in  allogeneic reactions, 
since the generation ofeffector T cells appears for the most part to be genetically 
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controlled by  determinants encoded for by  genes of the  MHC  SD  regions. 
However, we present in this report results indicating that AFP can actively 
inhibit the in vitro generation of CTLs even in the very same strain combina- 
tions in which AFP has little or no suppressive effect on the proliferative phase. 
Strain combinations were also found in which the CTL development proved 
refractive to the suppressive activity of AFP; however, such reactions always 
contained, in addition to the MHC difference(s), certain undefined lymphocyte- 
activating non-MHC loci  differences. Thus, the genetic relationship between 
responding and stimulating cells largely predetermines whether or not AFP 
will  inhibit the generation of CTLs.  These data,  together with those of the 
previous paper (9), allow us to speculate about possible  mechanisms for AFP- 
induced suppression ofT-cell-mediated  reactions. 
Materials and Methods 
Mice.  Inbred strains of mice used in this study and maintained in this laboratory are AQR, 
B10.A, B10.BR/cd, B10.D2/n,  B10.G,  B10.S,  B10.S(7R),  B10.T(6R),  CBA/H, CBA-H-2  ka, C57BL/ 
6Born, and DBAJ2. Breeding pairs of AQR were kindly provided by Dr. E. Simpson (Transplan- 
tation Biology, Clinical Research Center, Harrow, Middlesex, England). The mutant strain CBA- 
H-2  ka  was  obtained  from  Dr.  L.  C.  Andersson  (Transplantation  Laboratory,  University  of 
Helsinki,  Helsinki, Finland).  Both male and female mice ranging in age from 4 to 24 wk were 
utilized. 
AFP.  AFP was isolated and purified as described elsewhere (2, 9). 
MLC.  The  complete  protocol  for  the  MLC  reactions,  including the  description  of culture 
medium  and  preparation  of splenic T  lymphocytes,  has  been detailed previously  (9).  Primary 
MLC were supplemented with 150 ~g/ml AFP or an equivalent amount of normal mouse serum 
(NMS). 
CML Assay.  CML were performed according to procedures detailed elsewhere (13) and are 
basically a  modification of the techniques described by Alter et al.  (14).  The effector cells were 
generated  in primary  MLC.  The primed lymphocytes were collected from the mixed cultures, 
pooled, centrifuged,  and washed twice in medium supplemented  with 2.5%  fetal bovine serum 
(Microbiological Associates, Walkersville, Md). 
Lipopolysaccharide (LPS)-stimulated spleen cells or the in vitro grown P815 tumor were used 
as the target cells. Approximately 36 h  before the CML assay,  appropriate  target cell cultures 
containing 12.0  ×  l0  s spleen cells in 5.0 ml serum-free medium were established in culture dishes 
(3002,  BioQuest, BBL & Falcon Products,  Becton, Dickinson & Co., Cockeysville, Md.).  Target 
cells were incubated  2 h  then stimulated with 25-50  /~g/ml LPS prepared by Dr. J.  Andersson 
(Department of Immunology, Uppsala University, Uppsala, Sweden). At time of assay the target 
cells were collected, centrifuged, resuspended in 0.4 ml of supernate removed from the centrifuged 
cells, and labeled 1 h with 400-500  ~Ci Na2~lCrO4. The labeled cells were washed three times in 
medium. 
Cell destruction  was  performed  in round-bottomed  Sterilin microtiter plates  (Sterilin  Ltd., 
Teddington, Middlesex, England) using various effecter cell numbers plus 1.0  × 104 labeled target 
cells. Cell destruction proceeded 4 h  at 37°C,  after which time the plates were centrifuged, the 
supernate  collected,  and  the  quantity  of  released  slCr  determined.  Percent  cytotoxicity  is 
expressed as 
51Cr-released~exp. 1J -  51Cr-released~spo,t~o,~  ×  100%. 
slCr-release~max~mum~ -  5~Cr-released~po~taneous~ 
Results 
The T-cell-mediated  cytotoxic reaction is generally dissociated into a recogni- 
tive  phase,  in  which  the  recognition of alloantigens  results  in  the  clonal 
proliferation of specific  antigen-activated cells,  and  a  destructive phase,  in 
which activated cells within the responding population demonstrate cytotoxic 362  INHIBITION  OF  CYTOTOXIC  T  LYMPHOCYTE  DEVELOPMENT 
activity against cells bearing the sensitizing alloantigens. Genetic studies (15, 
16) have revealed that the in vitro development of CTLs apparently requires: 
(a) activation of a hypothesized proliferating helper cell population by alloanti- 
gens of the MHC,  and  (b)  sensitization of the CTL precursor population by 
serologically-defined MHC  alloantigens, or antigens of loci  closely linked to 
genes  encoding for  the  SD  determinants,  concurrently present  during  the 
activation phase.  In the mouse, lymphocyte activation as measured by MLC 
can be induced by genetic differences associated with the MHC (17, 18) or with 
loci segregating independently of the MHC (19-22) (referred to as non-MHC loci 
in the present report). The various regions and subregions comprising the MHC 
contain genes which code for at least two distinct classes of membrane-bound 
MLC-activating products.  The K  and D  regions encode for the classical SD 
determinants, whereas the I region genes encode for the Ia antigens. Both the 
SD  and  Ia  molecules, besides initiating lymphocyte proliferation,  appear to 
function as target antigens for cytotoxic T lymphocytes in CML (14, 23). Two 
MLC-stimulating non-MHC antigenic systems of interest for the present inves- 
tigation are the Mls locus (19, 20) and an as yet undefined system (22). These 
two non-MHC systems are readily distinguishable from one another through 
lymphocyte-typing  analysis, i.e., Mls locus products induce lymphocyte prolif- 
eration  only  if there  is  concommitant recognition  of MHC  I  region  gene 
products, whereas the undefined non-MHC system stimulates T lymphocytes 
directly  (22). Neither of the  non-MHC  alloantigens  apparently  function as 
target antigens for CTLs.  However, studies by Schendel and Bach  (24) and 
Wagner et al.  (25) have indicated that the presence of non-MHC lymphocyte- 
activating alloantigens during the proliferative phase can substitute for the 
MHC differences which normally induce the MLC necessary for the generation 
of CTLs.  These four classes  of determinants, together with their presently 
known functions, are listed in Table I. In addition, Table I indicates how these 
four systems are further delineated by the differential activity AFP exerts on T- 
cell proliferation induced by each system (9). Note that while AFP generally 
suppresses proliferative reactions involving I region recognition (including anti- 
Mls locus responses), it has little or no effect on reactions against SD region 
determinants and actually has the potential to enhance reactions involving the 
undefined non-MHC system. 
AFP-Induced Suppression  of the In Vitro Development of  CTLs.  Generation 
of mature CTLs in the absence or presence of AFP has been investigated using 
congenic resistant  partner  strains  possessing  a  variety  of MHC-associated 
genetic differences. One representative reaction involving a whole MHC differ- 
ence, the response of purified B10.BR splenic T lymphocytes against X-irradi- 
ated B10.D2/n spleen cells, is depicted in Fig.  1. The kinetics of primary MLC 
activation revealed the expected suppression of the proliferative responses in 
cultures containing AFP (Fig.  1A). After peak tritiated thymidine ([3H]TdR) 
incorporation, the NMS-generated and the AFP-generated cells were examined 
in CML for their capacity to elicit cytolysis. Whether these two populations of 
effector cells are compared on a culture to culture basis (Fig.  1 B) or on a cell to 
cell  basis  (Fig.  1C),  similar  results  were  obtained:  NMS-generated blasts 
specifically lysed the LPS-stimulated B10.D2/n target cells, whereas the AFP- 
generated cells exhibited no (or only marginal) cytolytic activity. AMMON  B.  PECK,  ROBERT  A.  MURGITA,  AND  HANS  WIGZELL  363 
TABLE  I 
List of Important Histocompatibility  Antigenic Systems Influencing the 
Control of the T-Cell-Mediated Cytotoxic Reaction and the Effects of  AFP on 
the Proliferative Phase 
Induction of 
Antigenic sys-  MLC activa-  Effects of AFP on MLC~  Target anti- 
tem*  tion*  gen in CML§ 
Ia  + + +  Suppression  +/- 
SD  + +  No effect or  slight  + + + 
suppression 
Mls-Locus  +  Suppression  - 
Non-MHC  ++  No  effect  or  en-  - 
hancement 
* Klein (17), Shreffler and David (18), Festenstein et al. (19, 20), and Peck et al. (22). 
* Peck et al.  (9). 
§ Nabholz et al.  (23), Alter et al.  (14), and Peck et al.  (13). 
Data presented in Fig. 1 C also indicate that the addition of AFP to the CML 
assay failed to alter the cytotoxic response of the CTLs.  No significant differ- 
ences in the percent 51Cr-release values over the ratios of effector to target cells 
tested was observed between the CML assays containing AFP and those not 
containing AFP.  This  would indicate that the  killing mechanism per se  of 
mature CTLs is not altered significantly by AFP, and, at the same time, AFP 
does not block or interfere with recognition of the target cell antigens. 
MHC recombinant strains possessing limited genetic differences permit the 
study of the effects of AFP on the generation of CTLs in allogeneic reactions 
induced by individual SD regions of the MHC.  Data presented in the previous 
report  (9)  suggested that  AFP acts primarily on a  subset of T  lymphocytes 
which demonstrate strong proliferative reactivity against products of the MHC 
I region genes, while failing to inhibit proliferative responses against isolated 
SD region differences. It might be predicted, therefore, that AFP should have 
little or no effect on the generation of CTLs in such genetic situations. To test 
this possiblity, a  number of strain combinations possessing isolated MHC SD 
region incompatibilities were examined to determine if AFP could inhibit CTL 
development. Results  presented in  Table II  show the effects of AFP in  the 
generation of CTLs  in  three selected reactions directed specifically against 
known SD  region products.  In each combination, AFP clearly inhibited the 
development of killer T cells, as measured in CML,  despite the fact that cell 
proliferation, as measured by [3H]TdR incorporation, proved similar in cultures 
containing AFP and in the control cultures. These three strain combinations 
represent three distinct genetic situations.  The first combination, AQR anti- 
B10.A,  is an anti-K region reaction. Primed lymphocyte-typing analysis sug- 
gests that the stimulating alloantigen recognized by the responding cells is 
associated  with  the  SD  specificity H-2.23. Likewise,  the  reaction  of B10.S 
towards  B10.S(7R) appears  to  be  induced by the  MHC  D  region-associated 
alloantigen defined by the two specificities H-2.4 plus H-2.40 present on the SD 
molecule (A. B.  Peck, unpublished data). Reactivity between strains CBA-H- 
2  ka and CBAJH is believed to result from a gain-loss mutation associated with 
the MHC K region. Thus, lymphocyte proliferation and cytotoxicity are most 364  INHIBITION  OF  CYTOTOXIC  T  LYMPHOCYTE  DEVELOPMENT 
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FIG.  I.  Suppression of  the in vitro  generation of  CTLs by AFP in a reaction  involving a 
whole MHC  haplotype difference.  A. Kinetics  of  MLC activation  of  purified  B10.BR splenic 
T lymphocytes  stimulated with  X-irradiated  B10.D2/n  spleen  cells  in  the absence (@------0) 
or  presence (O  O) of  150/~g/ml  AFP. B. Comparison on a culture  to  culture  basis  of  the 
cytotoxic  reactivity  for  B10.BR anti-B10.D2/n cells  generated  in  the presence or absence  of 
AFP. After peak [SH]TdR incorporation,  equal portions  of  the NMS-generated and AFP- 
generated cell  cultures were tested in CML  on 1.0 ×  104 bICr-labeled,  LPS-stimulated 
B10.BR or B10.D2/n blast  cells.  Control reactions  contained 0.37 × 106 blasts  and AFP- 
generated  reactions  contained 0.24  × 10  e  blasts.  C. Comparison on a cell  to  cell  basis  of  the 
cytotoxic  reactivity  for  B10.BR anti-B10.D2/n cells  generated  in  the absence  or  presence of 
AFP. The  activated  cells  generated  in  NMS supplemented  control  cultures  and in  the  AFP- 
containing cultures  were collected  and standardized to equal numbers of  blast  cells,  then 
tested  for cytotoxic  activity  at  various  numbers,  ranging  from  0.025  x  100  to 0.4  x  100 
blasts, on 1.0  x  104 51Cr-labeled, LPS-stimulated  B10.D2/n blasts in the absence  (@  ,) 
and presence (O  O) of 150 pg/ml AFP.  No cytolytic activity occurred on B10.BR target 
cells (in). 
probably  induced by the parent-mutation  strain-defined  SD specificity  H-2.60 
(26).  AFP,  therefore,  clearly  possesses the capacity to inhibit CML generated 
specifically against defined SD alloantigens. 
Lack of Suppression by AFP in the Generation of CTLs in Reactions against 
Strains DBA/2 and BIO.G.  One extensively  used system  in the study of T- 
cell-mediated cytotoxicity is the activation of lymphocytes with cells carrying 
the  MHC  d  haplotype,  particularly  from  DBA/2,  followed  by  testing  for 
cytolysis  on  the  in  vitro  maintained  P815  tumor  line.  The  recent  studies  of 
Sheppard et al.  (10) have indicated that AFP does not inhibit the generation of 
CTLs in such a reaction. We have also noted similar results using either C57BL/ 
6 or CBA/H as the responding strain against DBA/2, as shown in Table III.  Of 
major interest here is the fact that DBAJ2 cells have been shown previously (9) 
to  carry  non-MHC  alloantigen  systems  to  which  the  resulting  lymphocyte 
activation proved refractive to the inhibitory activity of AFP. It is not surpris- 
ing, therefore, that both the NMS-generated cells as well as the AFP-generated 
cells  elicited  strong  CML  on  P815  tumor  targets  or  LPS-stimulated  DBA/2 
target blasts. 
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TABLE  II 
AFP-Induced Suppression of CTL Generation  in Strain Combinations Possessing 
Isolated MHC SD Region Differences 
Respond-  Stimulating  Genetic differ-  [SH]TdR  incor- 
Culture  poration*  Mean  Target  cellst  CML§ 
ing  strain  strain  ences 
cpm _+ SD 
AQR  BI0.A  K Region 
BI0.S  BI0.S(7R)  D Region 
CBA-H-2  ka  CBA/H  SD Mutation 
% 
NMS  18,650  __ 487  AQR  -5.4 
B10.A  28.4 
+ AFP  19,035  _+ 777  AQR  -5.2 
B10.A  -1.8 
NMS  27,902  _ 2,406  B10.S  -3.6 
B10.S(7R)  26.4 
+ AFP  25,328  __. 422  B10.S  -10.8 
B10.S(7R)  -5.3 
NMS  41,440  -+ 546  CBA-H-2  ka  -2.8 
CBA/H  24.5 
+ AFP  37,156  _+ 213  CBA-H-2  k~  -3.7 
CBA/H  6.5 
* [SH]TdR  Incorporation  measured at  time  of  CML assay  after  a 4-h  pulse  time. 
Target  cells  = LPS-stimulated  spleen cells.  Spontaneous  release  values ranged  from 8  to  32% of 
the maximum release. 
§ Ratio  of  effector  to  target  cells  = 30:1. 
be  refractive to AFP-induced suppression  of CTL development.  This  is  seen 
whether in strain combinations possessing SD  +  I  region incompatibility, as 
shown in Table III for the reaction AQR anti-B10.G, or in strain combinations 
possessing isolated SD region differences, as shown in Fig.  2 for the reaction 
B10.T(6R) anti-B10.G.  Although B10.G is generally considered an MHC  con- 
genic resistant partner strain of C57BL/10, its phenotypo clearly shows the pres- 
ence of the homozygous tfgene which C57BL/10 does not (17). B10.G, therefore, 
must carry a  large chromosomal segment outside of MHC which was also de- 
rived from the MHC donor strain. The fact that AFP failed to suppress the in 
vitro generation of CTLs suggests that,  similar to DBA/2,  B10.G possesses a 
lymphocyte-stimulating non-MHC  alloatigenic  system.  This  concept  is  now 
supported  further  by  both  primed-lymphocyte typing  and  newborn-thymus 
reactions (unpublished data). 
A  few interesting points concerning the differential effects of AFP in CML 
reactions  of AQR  anti-B10.A  (Table  II),  AQR  anti-B10.G  (Table  III),  and 
B10.T(6R)  anti-B10.G  (Fig.  2)  can  be  drawn  from  a  genetic analysis  of the 
strains  involved.  Strain  AQR  utilized  in  the  present  study  was  originally 
derived from a cross between (T138 × B10.A)F1 and C57BL/10. The recombinant 
strain was subsequently backcrossed four times to C57BL/10 before intercross- 
ing.  AQR,  therefore, carries a  considerable portion of the  C57BL/10 genome 
even though it is not a  full congenic resistant partner strain. Similarly, strain 
B10.T(6R)  was  derived  as  an  MHC  recombinant between  B10.A  and  a  tf-T 
(tufted-Brachyury) stock, but still carries both markers outside of the MHC. In 
contrast, B10.G was derived from a noninbred stock which also carried the two 366  INHIBITION  OF  CYTOTOXIC  T  LYMPHOCYTE  DEVELOPMENT 
TABLE III 
Failure of AFP to Suppress the in Vitro Generation of CTLs in Reactions against 
Strains DBA/2 or BIO.G 
Respond-  Stirnulat-  Genetic  differences  Culture  Target  cells*  % CML*  ing  strain  ing  strain 
C57BL/6  DBA/2  MHC, Mls, Non-MHC  NMS  C57BL/6  -4.6 
DBA/2  62.7 
+  AFP  C57BL/6  1.9 
DBAJ2  71.8 
CBA/H  DBA/2  MHC, Mls,  Non-MHC  NMS  P815  82.4 
+ AFP  P815  88.2 
AQR  BI0.G  MHC I,S,G,D  Regions  NMS  AQR  -9.8 
B10.G  22.8 
+ AFP  AQR  -13.4 
B10.G  24.3 
*  Target  cells  = LPS-stimulated  spleen  cells  or  the  in  vitro  maintained  P815  tumor line. 
Ratio  of  effector  to  target  cells  = 12.5:1  for  the  reactions  C57BL/6  anti-DBA/2  and CBA/H anti- 
DBA/2, or  30:1  for  the  reaction  AQR anti-B10.G. 
markers, tf  and T, and, as stated above, still  carries  the tf  marker genes. While 
the C57BL/10 background is normally a silent  background in in vitro lympho- 
cyte activation,  this  genetic information indicates that these three strains most 
likely  possess genetic material of  non-C57BL/10 origin outside of, but linked to, 
the MHC.  It  is  not surprising,  therefore,  that unexpected lymphocyte activation 
and  activity occurred  between  these  presumed  congenic  resistant partner 
strains. Although  one  might  expect  that AQR  would  recognize  non-MHC 
components  on both B10.G and B10.A cells,  only the reaction against B10.G 
proved refractive to AFP-induced  suppression of CML.  Similarly, since both 
B10.T(6R) and B10.G were derived from strains carrying tf  and T markers, one 
might expect these two strains to be quite similar throughout chromosome  17 
and thereby see the CML  reaction of  B10.T(6R) anti-B10.G suppressed by AFP 
in a normal manner. These deviations from the expected probably stem from 
the fact that AQR  is derived in part from B10.A and is nearly congenic with 
C57BL/10  in the non-MHC  background,  while the combinations  AQR-B10.G 
and B10.T(6R)-B10.G  have major non-MHC  genetic differences arising from 
their independent  derivations. Linkage  studies are now being conducted  to 
determine if  the non-MHC  lymphocyte stimulating alloantigenic system asso- 
ciated with B10.G is identical  to that of  the DBA/2 strain and whether it maps 
to chromosome  17 (linkage group IX). Note, also,  that reactions of AQR  cells 
can be both suppressed by AFP  and refractive to the suppressive  activity of 
AFP. This indicates that the effects  of  AFP  are not inherent in the genetics of 
the responding strain. 
The differential  effect  of  AFP on CML, shown in Tables II  and III,  is a highly 
reproducible  phenomenon  and  there  is no  indication that  it results from 
variability in different samples of AFP.  Three different preparations of AFP 
have been utilized  in the present study. All experiments except the reactions of 
CBA-H-2 ka anti-CBA/H  (Table  II) and CBA/H  anti-DBA/2  (Table III)  were 
performed  with  one  AFP  preparation.  Thus,  we  would  conclude  that the AMMON  B.  PECK,  ROBERT  A.  MURGITA, 
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FIG.  2.  Lack  of an  AFP-induced  suppression  of CTL  development  in  the  reaction  of 
B10.T(6R)  against  B10.G.A.  Kinetics of MLC activation of purified B10.T(6R)  splenic T 
lymphocytes responding against B10.G spleen cells in the absence (0  @) and presence 
(O  O) of 150/~g/ml of AFP.  B. CML of NMS-generated (@------O,  •  A) and AFPo 
generated (O  O,  A  Z~) B10.T(6R) anti-B10.G blast cells. After peak [SH]TdR incor- 
poration in MLC, cells from each culture were collected and standardized to equal numbers 
of blast cells, then tested for cytotoxic activity at various numbers, ranging from 0.02  x  108 
to 0.32  x  108 blasts, on 1.0  x  104 61Cr-labeled B10.G (e or O) and B10.T(6R) (• or A) target 
cells. 
inhibition or lack of inhibition of the in vitro generation of CTLs depends to a 
large extent on the genetic relationship  between responding  and  stimulating 
strains. 
Inhibition  of the  AFP-Induced Suppression  of CTL  Development  by  the 
Introduction  of Nonsuppressible  Anti-Non-MHC Reactions  into  the Primary 
MLC.  Data obtained thus far indicate that  the presence of AFP during the 
activation  phase  exerts  in  general  a  selective  suppressive  activity  on  the 
subsequent development  of CTLs.  This  inhibition,  while  independent  of the 
suppressibility  of the  MLC  activation  phase  (Table  II),  is  dependent  on  the 
genetic relationship between the responding and stimulating strains (Table III). 
For example,  in this  study we have found that  both DBAJ2 and  B10.G cells, 
when utilized as the stimulating antigen, are capable of initiating events which 
circumvent  the  mechanism(s)  of AFP  suppression.  The  possibility  that  this 
circumvention results from the presence of non-MHC components is suggested 
from a comparison of the two reactions B10.BR anti-B10.D2/n (Fig. 1) and CBA/ 
H anti-DBAJ2 (Table III). Both reactions are MHC k anti-d responses; however, 
CBA/H  and  DBA/2  differ  genetically  at  MLC-activating  non-MHC  loci, 
whereas  B10.BR  and  B10.D2/n  are  congenic  resistant  partner  strains  and 
considered to be genetically identical at all non-MHC loci. 
To test the possibility that  the  introduction  of a  nonsuppressible  anti-non- 
MHC reaction present during the priming phase can cause the circumvention of 
the mechanism of AFP suppression, we have utilized the protocol of a three-cell 
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cells on two different stimulating strains. Purified splenic T lymphocytes from 
B10.D2/n  were stimulated in vitro in the absence and presence of AFP with 
either  X-irradiated  B10.BR  plus  syngeneic  B10.D2/n  cells  or  X-irradiated 
B10.BR plus DBA/2 cells. The response of B10.D2/n against DBA/2, considered a 
pure anti-non-MHC reaction, is characterized by lymphocyte proliferation but 
no generation of CTLs (13). Furthermore, the presence of AFP in the B10.D2/n 
anti-DBA/2 reaction tends to enhance the resulting lymphocyte proliferation 
(9). On day 6 of primary MLC, the activated cells from each culture were tested 
in CML  for their killing potential.  Results,  summarized in Table IV,  reveal 
that the addition of DBA/2 cells to the otherwise AFP-suppressible B10.D2/n 
anti-B10.BR reaction inhibits the suppression and permits the development of 
CTLs with specificity for the SD determinants of B10.BR. 
Discussion 
Earlier analysis (9)  of the impact exerted by AFP on the recognition and 
subsequent proliferation of T  lymphocytes reacting in  MLC  against defined 
histocompatibility  alloantigens  revealed  a  highly  selective  activity  in  the 
suppression of lymphocyte responses. In general, AFP inhibited Ly 1  + T blast 
cells reacting against I region structures (including reactions against Mls locus 
products whose recognition apparently requires concommitant recognition of I 
region gene products), but failed to  inhibit  Ly 2  + T  cells stimulated by SD 
alloantigens. Thus, it seemed clear that AFP exerted its suppressive activity in 
MLC  via  selective interference with I  region triggering systems.  However, 
results of the present study, which has concentrated primarily on the capacity 
of AFP to suppress the effector phase of the T-cell-mediated cytotoxic reaction, 
suggests a broader spectrum of regulatory activity. For example, AFP, when 
present  during the  primary  activation  phase  of T-cell  responses,  not  only 
suppressed  the  subsequent  in  vitro  generation of effective CTLs  in  strain 
combinations with I plus SD region differences (Fig.  1),  but also in congenic 
strain combinations possessing only SD region differences where the prolifera- 
tive  phase  was  unaffected (Table  II).  If AFP  interfered only with  I  region 
triggering, then it would have been expected that at least in reactions directed 
against isolated MHC SD region-associated gene products not only the prolifer- 
ative  but  also  the  cytotoxic phase  would  have  remained refractive to  the 
suppressive activity of AFP. 
How AFP suppresses the generation of CTLs remains to be determined, but 
any  discussion  concerning a  possible  mechanism first  necessitates  a  basic 
understanding of the events which control development of killer T cells in the 
normal situation. One widely held hypothesis (27) argues that a subpopulation 
of T cells, the CTL precursor cells, initiates the reaction by first recognizing 
alloantigens of the MHC SD regions and thereafter differentiating to a poised- 
CTL receptive to a help-signal. A second subpopulation of T cells, the prolifer- 
ating helper cell, recognizes and responds against the lymphocyte-activating 
determinants of the MHC and then, either through cell-cell contact or a soluble 
factor, collaborates with the poised-CTL  pool.  It is the T-T cell collaboration 
which induces the final differentiation of the poised-CTL  to an active killer T 
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TABLE  IV 
Inhibition of the AFP-Induced Suppression of T-Cell-Mediated Cytotoxicity  by Addition 
of Third Party Stimulating Cells with Non-MHC Genetic Differences 
[SH]TdR Incor-  Target 
Respond-ing Stimulat-  Genetic  differences  Culture  poration  Mean 
strain  ing  strain  cpm _+ SD  cells* 
% CML~ 
B10.D2/n 
BI0.D2/n 
BI0.D2/n 
DBAJ2 
MHC + None  NMS  10,148  -+ 649  B10.D2/n  -6.4 
B10.BR  38.9 
+ AFP  2,491 ± 152  B10.D2/n  -9.2 
B10.BR  -4.1 1 
MHC + Non-MHC  NMS  9,878 ± 491  BI0.D2/n  -9.6 / 
B10.BR  42.0 ! 
+ AFP  4,993  ±  335  B10.D2/n  -7.6| 
B10.BR  22.9 .$ 
* Target cells = LPS-stimulated  spleen cells. Spontaneous  release values are: B10.D2/n 598 --- 22, 
B10.BR 420 ± 11. Maximum  release values are: B10.D2/n 2,689 ± 218, B10.BR 2,159 ± 407. 
Ratio of effector  to target cells = 40:1. 
Plate (28) and Soperi et al.  (29) which suggest that the pre-killer T cell must 
receive  two  signals,  one  of which  eminates  from the  helper  T  cell,  before 
differentiating to a specific effector T lymphocyte. 
It is now clear that AFP-induced suppression of CTL development, similar to 
the AFP-induced suppression of lymphocyte proliferation in MLC (9), is depend- 
ent  on  parameters  controlled  in  part  by  the  genetic  relationship  between 
responding and stimulating strains.  This is seen in a  comparison of the two 
reactions B10.BR anti-B10.D2/n  (Fig.  1)  and CBAJH anti-DBA]2  (Table  III). 
Both reactions are MHC k  anti-d, but the latter reaction is also characterized 
by the presence of numerous MLC-activating non-MHC differences. The fact 
that  inhibition of the  generation of CTLs was  only effected by AFP  in the 
reaction  between  the  congenic  resistant  partner  strains,  B10.BR-B10.D2/n, 
suggests that the non-MHC component is a responsible factor in circumventing 
the mechanism of AFP suppression. This concept is strongly supported by the 
three-cell experiments in which the introduction of a  non-MHC lymphocyte- 
activating difference into the primary MLC of an otherwise AFP-suppressible 
reaction led to the development of CML activity (Table IV). 
In view of the results observed in beth the present study and the previous 
paper  (9),  three  mechanisms of AFP-induced suppression  of T-cell-mediated 
cytotoxicity appear feasible. First, AFP may directly suppress several distinct 
subpopulations  of T  lymphocytes,  including  the  Ly  1  +  proliferating  T-cell 
responsive against MHC  I  region-gene products and the CTL precursor cell. 
Second, AFP may interfere solely with the proliferating helper T-cell response 
against MHC-associated lymphocyte-activating  determinants and in this man- 
ner block the T-T cell collaboration necessary for the differentiation of the CTL 
precursor to a  killer cell to occur.  Third, AFP may inhibit the production of 
CTLs  by  inducing suppressor  T  cells  capable  of blocking either  directly or 
indirectly the collaborating T-cell populations.  This third possibility receives 370  INHIBITION  OF  CYTOTOXIC  T  LYMPHOCYTE  DEVELOPMENT 
indirect support from evidence presented in another test system (12)  2 in which 
AFP was shown capable of activating Ly 1+,2 T cells in vitro which efficiently 
blocked helper T-cell-dependent antibody synthesis. 
At  present  we  believe  that  the  key  in  proposing  a  mechanism  for  AFP 
suppression  comes  from  the  observation  that  the  presence  of lymphocyte- 
activating non-MHC determinants  can prevent suppression of CTL formation 
by AFP (Tables III and IV). Studies of Schendel and Bach (24) and Wagner et 
al.  (25)  indicate  that  lymphocyte  activation  by non-MHC  determinants  also 
provides the helper T-cell signal to the poised-CTL or CTL precursor cell. Thus, 
it would seem most probable that the regulatory activity of AFP, by whatever 
means the  actual suppression  is elicited,  lies at the level of the helper T-cell 
signal. This point is presently being investigated. 
In conclusion, AFP is endowed with selective ability to abrogate the in vitro 
generation  of CTLs  in  allogeneic  reactions.  This  selective  activity  not  only 
indicates a  potential in vivo relevance of AFP as an immunoregulatory factor, 
but also provides us with a new approach in the dissection of the T-cell-mediated 
cytotoxic reaction. Equally important, however, may be the possible use of AFP 
as a selective reagent in obtaining specific, alloantigen-reactive T-cell subsets. 
Summary 
Alpha-fetoprotein  (AFP), a  major component of fetal and newborn sera, was 
shown to exert significant immunosuppressive activity on the in vitro genera- 
tion of cytotoxic T lymphocytes (CTLs). This suppression proved independent of 
the suppressibility of the mixed leukocyte culture activation phase, since strain 
combinations  whose  proliferative  responses  were  refractive  to  AFP-induced 
suppression also failed to develop demonstrable CTLs in the presence of AFP. 
Several  strain  combinations  were also found  in  which  normal  generation  of 
CTLs occurred in cultures  containing  AFP.  This refractive nature  correlated 
with  the  presence  of nonsuppressible  lymphocyte-stimulating  alloantigenic 
systems on the  stimulating  cell population.  These  data  provide the basis for 
proposing several possible mechanisms for AFP-induced suppression of T-cell- 
mediated  cytotoxicity,  as well  as  suggesting  that  the  primary  target  of this 
suppression is the proliferating helper T  cell precommited to respond towards 
the  major  histocompatibility  complex-associated lymphocyte-activating  deter- 
minants. 
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